pharma.markets

pharma.markets

  • HOME
  • Imprint

Month: March 2021

IPS Selected by Apiject as a Key Partner for Greenfield Blow−Fill−Seal Aseptic Manufacturing Campus

30/03/2021 MaP 0

The ApiJect Campus represents ApiJect’s future of manufacturing, capable of producing up to an estimated 3 billion Blow-Fill-Seal (BFS) prefilled injectors and other devices per […]

BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

26/03/2021 MaP 0

BioNTech SE today announced that the European Medicines Agency (EMA) approved the manufacturing of the COVID-19 vaccine drug product at the facility in Marburg. As part […]

EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union

26/03/2021 MaP 0

New stability data show vaccine can be stored at -25°C to -15°C for a total of two weeks and support decentralized distribution plans for vaccination […]

Comunidad Valencia – These are the groups to be vaccinated from 24.3.2021 onwards

24/03/2021 MaP 0

The reactivation of immunisation for the educational community will begin next Friday. The launch of the vaccination is to see, once again, the light at […]

Pivotal Phase III study shows Roche’s Tecentriq helped people with early lung cancer live longer without their disease returning

22/03/2021 MaP 0

First Phase III study to show that a cancer immunotherapy improves disease-free survival in people with resectable early stage lung cancer compared to best supportive […]

Novartis appoints Karen Hale as Chief Legal Officer

22/03/2021 MaP 0

Novartis announced today the appointment of Karen L. Hale as Chief Legal Officer. She will report to Vas Narasimhan, M.D., CEO of Novartis and become […]

Roche provides update on tominersen programme in manifest Huntington’s disease

22/03/2021 MaP 0

Dosing to stop in Phase III clinical study of tominersen following recommendation from an Independent Data Monitoring Committee (iDMC) No new safety signals were identified […]

Statement by HHS Secretary Xavier Becerra on the Anniversary of the Affordable Care Act

22/03/2021 MaP 0

“President Biden promised to bring down health care costs and that is exactly what we at the Department of Health and Human Services will do, […]

Spain – Vaccines stats on March 22nd 2021

22/03/2021 MaP 0

The autonomous communities have administered a total of 6,321,908 doses of Pfizer-BioNTech, Moderna and AstraZeneca’s covid-19 vaccines up to Monday, 328,545 of them during the […]

copyright IPS

IPS Joins Grantek Partner Program to Advance Industry 4.0 and Pharma 4.0™ Solutions Offering

22/03/2021 MaP 0

Grantek, a leading manufacturing business consultant and systems integrator, is launching a partner program for Engineering, Procurement and Construction (EPC) firms. This program will allow […]

Clofamizine, a leprosy drug, is effective against SARS-CoV-2 infection

20/03/2021 MaP 0

Clofamizine, a drug used to treat leprosy, is effective against SARS-CoV-2 infection in human cells and hamsters, according to a study published Tuesday in the […]

IPS and BioKansas Partner to Host Community Forum – Cell & Gene Therapy

20/03/2021 MaP 0

This interactive forum discusses the latest in cell and gene therapy trends and their potential to impact the economy. Blue Bell, Pennsylvania, March 19, 2021 […]

Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies

17/03/2021 MaP 0

Merck will add a single-use assembly production unit at its Life Science Center in Molsheim, France. € 25 million investment in Molsheim, France, will create […]

Biden Administration to Invest $150 Million to Expand Access to COVID-19 Treatments in Underserved Communities

17/03/2021 MaP 0

As part of the Biden Administration’s ongoing efforts to promote health equity in response to the COVID-19 pandemic, the U.S. Department of Health and Human […]

Roche launches SARS-CoV-2 variant test to help monitor emerging coronavirus mutations

16/03/2021 MaP 0

The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission Accurate detection and […]

Posts navigation

1 2 »

Translation

Search

Categories

  • Age.related Degeneration
  • Alzheimer
  • Animal health
  • Asthma
  • Bioscience
  • Cancer
  • Conferences
  • Cosmetics
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Food
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • Innovation
  • Mental Health
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • Spain
  • Sports
  • Therapy
  • Trade Fair
  • UN
  • Vaccines
  • Valencia Comunidad
  • WHO

Reports

  • SciBase and Schweiger Dermatology Group partner to advance skin cancer detection in select New Jersey locations
  • BioNTech Announces New ADS Repurchase Program
  • Merck Announces Expanded Partnership with Beyond Benign to Increase Global Access to Green Chemistry Education
  • Bayer expands global clinical program for darolutamide in prostate cancer
  • Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation

Archive

  • March 2023 (18)
  • February 2023 (11)
  • January 2023 (6)
  • December 2022 (16)
  • November 2022 (11)
  • October 2022 (14)
  • September 2022 (1)
  • August 2022 (4)
  • July 2022 (3)
  • June 2022 (8)
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • SciBase and Schweiger Dermatology Group partner to advance skin cancer detection in select New Jersey locations

    29/03/2023 0
  • BioNTech Announces New ADS Repurchase Program

    28/03/2023 0
  • Merck Announces Expanded Partnership with Beyond Benign to Increase Global Access to Green Chemistry Education

    27/03/2023 0
  • Bayer expands global clinical program for darolutamide in prostate cancer

    23/03/2023 0
  • Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation

    21/03/2023 0
Archives
  • March 2023 (18)
  • February 2023 (11)
  • January 2023 (6)
  • December 2022 (16)
  • November 2022 (11)
  • October 2022 (14)
  • September 2022 (1)
  • August 2022 (4)
  • July 2022 (3)
  • June 2022 (8)
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid bayer biontech cancer commission companies coronavirus covid-19 covid19 economy elpais.com emergency eu europe european fda food global guarantee health hygiene investment links medical merck novartis pandemic pfizer production recommendations region response roche safety scheme sector spain state statistics support test vaccine who

Copyright © 2023 | WordPress Theme by MH Themes

Cookie Consent with Real Cookie Banner